Fig. 7From: Administrative prevalence and incidence, characteristics and prescription patterns of patients with migraine in Germany: a retrospective claims data analysisHealthcare professional group who made the first diagnosis of migraine in the German Company Sickness Fund Database 2009–2016. Data are shown for all patients (overall) and patients grouped according to the number of restricted Group 1 (propranolol, metoprolol, flunarizine, topiramate and amitriptyline, but not onabotulinum toxin A or valproic acid) preventive medications from different classes prescribed during 2009 to 2016. Data shown are for healthcare professional groups/hospital with > 1.5% of first visits overall. n number of patients with dataBack to article page